Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $409000.0.

  • Biodesix's Other Non Operating Income rose 935.83% to $409000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $558000.0, marking a year-over-year increase of 84400.0%. This contributed to the annual value of -$248000.0 for FY2024, which is 423333.33% down from last year.
  • Biodesix's Other Non Operating Income amounted to $409000.0 in Q3 2025, which was up 935.83% from $51000.0 recorded in Q2 2025.
  • Biodesix's Other Non Operating Income's 5-year high stood at $3.1 million during Q3 2021, with a 5-year trough of -$6.4 million in Q4 2022.
  • For the 5-year period, Biodesix's Other Non Operating Income averaged around -$752222.2, with its median value being -$31500.0 (2023).
  • Data for Biodesix's Other Non Operating Income shows a peak YoY increase of 1860000.0% (in 2024) and a maximum YoY decrease of 3880000.0% (in 2024) over the last 5 years.
  • Over the past 5 years, Biodesix's Other Non Operating Income (Quarter) stood at -$97000.0 in 2021, then tumbled by 6547.42% to -$6.4 million in 2022, then skyrocketed by 100.03% to $2000.0 in 2023, then surged by 18600.0% to $374000.0 in 2024, then grew by 9.36% to $409000.0 in 2025.
  • Its Other Non Operating Income stands at $409000.0 for Q3 2025, versus $51000.0 for Q2 2025 and $98000.0 for Q1 2025.